A Brussels court is weighing whether Poland must pay Pfizer €1.4 billion for undelivered COVID vaccines, in a case that could ...
Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...
Ventripoint Diagnostics (TSXV: VPT) (OTCPK: VPTDF) is building a subscription business around technology that converts standard 2D ultrasound images into detailed 3D heart models with MRI-level ...
Over the past five years, Novavax ( NVAX 6.01%), a vaccine maker, lost more than 90% of its market value. Though it succeeded ...
The FDA has granted breakthrough therapy designation for litifilimab in patients with cutaneous lupus erythematosus, according to a press release from manufacturer Biogen. Litifilimab (Biogen) is a ...
Pfizer has spent billions of dollars on acquisitions in the past few decades. Its biggest deals include Warner-Lambert, ...
First patients dosed in DAYBreak™ registrational program for bexobrutideg in relapsed/refractory CLLPresented Phase 1 results at ASH 2025 that ...
The Chosun Ilbo on MSN
Roche's obesity drug shows 22.5% weight loss in phase 2 trials
Swiss pharmaceutical company Roche announced on the 27th (local time) that its obesity treatment pipeline ‘CT-388’ recorded a ...
A novel neoadjuvant therapy combining PD-1 blockade and chemoradiotherapy shows promising results in treating advanced rectal ...
Eli Lilly plans to expand its hearing loss therapy pipeline by collaborating with Seamless Therapeutics to apply the company’s next-generation gene-editing approach, based on programmable recombinases ...
Although it is the leading infectious cause of birth defects, patients and some doctors know little about cytomegalovirus.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results